Cresco Labs Debuts New Dispensary in Tamarac, Florida
New Sunnyside location enhances patient access in Broward County
Cresco Labs has opened its 31st Florida dispensary, a Sunnyside location in Tamarac at 6001 N University Drive, as the company continues expanding in one of the nation's largest medical cannabis markets.
Florida has over 750,000 registered medical marijuana patients, making it the third-largest medical cannabis market in the U.S. after California and Oklahoma. The state does not allow recreational sales.
"Our expansion in Florida is a testament to our commitment to providing quality cannabis products and enhancing patient accessibility," said Charles Bachtell, Cresco Labs CEO.
Florida's Medical Market
The state's medical program, approved by voters in 2016, has grown rapidly. Qualifying conditions include cancer, epilepsy, glaucoma, HIV/AIDS, PTSD, ALS, Crohn's disease, Parkinson's disease, and multiple sclerosis, among others.
Patients must obtain a physician recommendation and register with the state's medical marijuana use registry. Once approved, they can purchase products from licensed dispensaries like Sunnyside.
The Tamarac location is Cresco's 72nd dispensary nationwide. The company operates in multiple states including Illinois, Pennsylvania, Ohio, and Massachusetts, though Florida represents one of its largest retail footprints.
Competitive Landscape
Florida's medical cannabis market includes major multi-state operators like Trulieve, which dominates with over 120 locations statewide, as well as Curaleaf, Verano, and AYR Wellness.
The competitive environment has driven innovation in products and services. Dispensaries offer delivery, online ordering, rewards programs, and educational resources to attract and retain patients.
Cresco's Sunnyside brand focuses on customer experience and product quality. The company manufactures many of its own products, giving it control over the supply chain from cultivation through retail.
Market Outlook
Florida voters will decide on a recreational cannabis ballot initiative in 2024. If approved, the market would expand significantly, though existing medical operators would have a head start in serving adult-use customers.
For now, companies like Cresco continue building their medical market presence in anticipation of potential future expansion.
This article is based on original reporting by Financial Post.
Original Source
This article is based on reporting from Financial Post.
Read the original articleOriginal title: "Cresco Labs Opens Sunnyside Tamarac, Expanding Patient Access in Broward County, Florida"
Related Topics
Related Stories
Industry NewsHemp Entrepreneur Fires Back at Industry Critics, Blames Consolidation
Hemp business owner John Grady argues regulatory pressure on hemp products isn't about consumer safety—it's about large cannabis operators using regulation to eliminate competition from smaller hemp companies.
Industry NewsNew York's Cannabis Program Shows Signs of Recovery After Rocky Start
Five years after legalizing cannabis, New York's market is stabilizing after regulatory delays and illicit competition nearly derailed the program. Housing Works executive details improvements in licensing, enforcement, and supply chain.
BusinessMichigan Cannabis Market Posts 7.8% Year-Over-Year Decline in March
Michigan's cannabis market posted $255.5 million in March sales, down 7.8% year-over-year despite monthly growth, as medical sales collapsed to just $0.4 million amid ongoing market saturation.
More from Alex Morgan
View all articles
Nebraska Senator Challenges State's Proposed Hemp Restrictions
Texas Judge Blocks Hemp Rules, Restores THCA Flower Sales
Al Harrington's 12 NBA Surgeries Led Him From Cannabis User to Researcher
